Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.

Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism. N Engl J Med. 2003 Nov 27; 349(22):2164-7; author reply 2164-7.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.